The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: Similarities and differences
- PMID: 36184036
- DOI: 10.1016/j.jbspin.2022.105469
The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: Similarities and differences
Keywords: EULAR; GRAPPA; Management; Patient; Psoriasis; Psoriatic arthritis; Recommendations.
Similar articles
-
GRAPPA 2023: Major Projects, Key Advances, and Milestones.J Rheumatol. 2024 Oct 1;51(Suppl 2):65-69. doi: 10.3899/jrheum.2024-0266. J Rheumatol. 2024. PMID: 39009384
-
Basic Science Session 1. Biomarkers for Psoriatic Arthritis Treatment Response and Joint Damage Progression: An Update on 2 Industry-GRAPPA Projects.J Rheumatol. 2022 Jun;49(6 Suppl 1):13-15. doi: 10.3899/jrheum.211320. Epub 2022 Apr 1. J Rheumatol. 2022. PMID: 35365582
-
GRAPPA 2021 Treatment Recommendations for Psoriatic Arthritis.J Rheumatol. 2023 Nov;50(Suppl 2):31-32. doi: 10.3899/jrheum.2023-0522. Epub 2023 Jul 7. J Rheumatol. 2023. PMID: 37419619
-
Treatment of psoriatic arthritis: management recommendations.Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S73-7. Epub 2015 Oct 15. Clin Exp Rheumatol. 2015. PMID: 26471459 Review.
-
Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations.Nat Rev Rheumatol. 2016 Dec;12(12):743-750. doi: 10.1038/nrrheum.2016.183. Epub 2016 Nov 10. Nat Rev Rheumatol. 2016. PMID: 27829672 Review.
Cited by
-
Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study.Adv Ther. 2023 Dec;40(12):5415-5431. doi: 10.1007/s12325-023-02693-w. Epub 2023 Oct 7. Adv Ther. 2023. PMID: 37804475 Free PMC article.
-
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study.RMD Open. 2024 Mar 26;10(1):e003977. doi: 10.1136/rmdopen-2023-003977. RMD Open. 2024. PMID: 38531621 Free PMC article. Clinical Trial.
-
JAK Inhibitors in Psoriatic Disease.Clin Cosmet Investig Dermatol. 2023 Oct 31;16:3129-3145. doi: 10.2147/CCID.S433367. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37927384 Free PMC article. Review.
-
Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis.J Pers Med. 2024 May 16;14(5):535. doi: 10.3390/jpm14050535. J Pers Med. 2024. PMID: 38793117 Free PMC article. Review.
-
Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry.Rheumatology (Oxford). 2024 Sep 1;63(9):2427-2432. doi: 10.1093/rheumatology/keae263. Rheumatology (Oxford). 2024. PMID: 38759119 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical